Secondary Neoplasm — Trials

Secondary Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

14,676 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 301–350 of 6,412 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06708949	A Randomized Phase 2 Trial of Nivolumab, Relatlimab Plus Ipilimumab vs. Nivolumab Plus Ipilimumab in First-line Advanced Renal Cell Carcinoma (RCC)	active not recruiting	Phase 2	52	M.D. Anderson Cancer CenterOTHER	1	Sep 11, 2026	clinicaltrials
NCT07381075	A Phase II Clinical Trial of Anti-EGFR Antibody-drug Conjugate (ADC) Combined With or Without Immune Checkpoint Inhibitors in the Neoadjuvant Treatment of Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma	recruiting	Phase 2	90	West China HospitalOTHER